S. 4781 proposes to expand the mission of the Export-Import Bank of the United States. The bill aims to prioritize support for domestic industries that produce goods and services related to exports, which is intended to create jobs in the U.S. and enhance the country's competitiveness in the global market.
Supporters of S. 4781 highlight its potential to boost American manufacturing and create jobs by focusing on critical industries. They argue that expanding the Export-Import Bank's mission will help strengthen the U.S. economy and ensure that American businesses can compete effectively on a global scale.
Critics of S. 4781 express concern that expanding the Export-Import Bank's mission could lead to increased government intervention in the economy and may favor certain industries over others. There are fears that this could result in misallocation of resources and potentially create market distortions, undermining the principles of free enterprise.
The analysis of Bill S. 4781, which aims to expand the mission of the Export-Import Bank of the United States, reveals no direct overlaps between the bill's subject matter and the top donor industries of sponsor Charles Schumer. The lobbying activity in this policy area includes contributions from various organizations, such as Altria Client Services and the American College of Clinical Pharmacy, but these do not directly relate to the export-related domestic industries emphasized in the bill. The total contributions from these lobbying entities do not suggest a significant financial influence on the bill's objectives, indicating that the risk of conflict of interest is minimal.
Moreover, the lack of direct industry overlaps suggests that the financial interests of the sponsor's donors are not aligned with the bill's focus on strengthening domestic critical industries and supporting U.S. employment through exports. This further reduces the likelihood of conflicts arising from donor influence. Voters should be aware that while lobbying exists in the broader context, it does not appear to compromise the integrity of this particular legislation.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| NATIONAL SLEEP FOUNDATION | SLEEP, INC. | undisclosed |
| SLEEP, INC. | SLEEP, INC. | undisclosed |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Charles Schumer, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
